Xtrackers FTSE 250 UCITS ETF 1D (XMCX)
Category UK Mid-Cap Equity
This ETF can be held in an Investment ISA, SIPP and Investment Account
Sell
1,864.60p
Buy
1,866.80p
-6.30p (-0.34%)
Prices updated at 24 Apr 2024, 07:59 BST
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The aim is for your investment to reflect the performance of the FTSE 250 Index (the "Reference Index") which is designed to reflect the performance of the shares of 250 medium sized UK companies listed on the London Stock Exchange which are not included in the FTSE 100 Index.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk profile
- Management
Growth of 1,000 as of 25 Apr 2024, 14:04
Trailing returns (%) as of 25 Apr 2024, 14:04
Annual performance (%)
Year | This fund | UK Mid-Cap Equity |
---|---|---|
31 Mar 13 - 31 Mar 14 | 19.20 | 22.48 |
31 Mar 14 - 31 Mar 15 | 7.07 | 7.79 |
31 Mar 15 - 31 Mar 16 | 1.08 | 4.22 |
31 Mar 16 - 31 Mar 17 | 14.83 | 14.39 |
31 Mar 17 - 31 Mar 18 | 5.08 | 8.38 |
31 Mar 18 - 31 Mar 19 | 0.74 | -0.98 |
31 Mar 19 - 31 Mar 20 | -18.90 | -18.39 |
31 Mar 20 - 31 Mar 21 | 44.72 | 49.30 |
31 Mar 21 - 31 Mar 22 | 0.22 | -4.48 |
31 Mar 22 - 31 Mar 23 | -8.07 | -9.74 |
31 Mar 23 - 31 Mar 24 | 8.38 | 6.93 |
Morningstar category: UK Mid-Cap Equity
Trailing returns (%)
Year | This fund | UK Mid-Cap Equity |
---|---|---|
1 Day | -0.41 | 0.01 |
1 Month | 0.39 | 0.42 |
3 Months | 3.75 | 3.94 |
6 Months | 17.73 | 17.02 |
1 Year | 5.73 | 3.89 |
3 Years annualised | -1.57 | -4.07 |
5 Years annualised | 2.15 | 1.40 |
Morningstar category: UK Mid-Cap Equity
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.